Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). (Q43562176)

24 November 2017

Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). (English)

1 reference

24 November 2017

3

1 reference

24 November 2017

Conacher M

1

1 reference

PubMed ID

11282208

24 November 2017

Alexander J

series ordinal

2

1 reference

PubMed ID

11282208

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

19

1 reference

24 November 2017

20-22

1 reference

24 November 2017

2965-2974

1 reference

Oral vaccine models: multiple delivery systems employing tetanus toxoid.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Optimal delivery of vaccines: clinical pharmacokinetic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

1 reference

7 January 2021

Oral immunization with influenza virus in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Studies on the adjuvant activity of non-ionic surfactant vesicles: adjuvant-driven IgG2a production independent of MHC control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Studies on the Mechanism of Bile Salt-Induced Liposomal Membrane Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Accurate determination of adjuvant-associated protein or peptide by ninhydrin assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

The stability of liposomes in vitro to pH, bile salts and pancreatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Membranes and bile formation. Composition of several mammalian biles and their membrane-damaging properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Activation patterns of murine T cells after oral administration of an enterocoated soluble antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

ISCOMS — a novel strategy for mucosal immunization?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Biodegradable microparticles for oral immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

The role of IL-10 in crossregulation of TH1 and TH2 responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Enteric immunization of mice against influenza with recombinant vaccinia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Secretory antibody following oral influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

Improvement of inactivated influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

IgG isotype distribution of local and systemic immune responses induced by influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900537-5

7 January 2021

10.1016/S0264-410X(00)00537-5

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11282208